Herombopag: Clinical Trials

7 trials of Herombopag, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 not yet recruiting, 1 completed, 1 recruiting. 3 Phase 2, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Phase 32Unknown 2
Not applicable1Not yet recruiting 1

Follow Herombopag: new trials by email Literature Review of Herombopag trials Research Report on Herombopag

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag
Herombopag - HER2-positive Breast Cancer
Not applicableNot yet recruitingZhenzhen Liu452025-10-312025-09-30
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
herombopag - Thrombopenia, Cervical Cancer
Phase 2Not yet recruitingPeking University Cancer Hospital & Institute302025-01-012024-12-20
Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
Herombopag - Immune Thrombocytopenia
Phase 3UnknownJiangsu HengRui Medicine Co., Ltd.1172023-01-232023-01-17
Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
Herombopag - Non Severe Aplastic Anemia, Untreated
Phase 2CompletedInstitute of Hematology & Blood Diseases Hospital, China542022-12-012025-08-05
Herombopag for Chemotherapy-induced Thrombocytopenia
Herombopag - Chemotherapy-induced Thrombocytopenia, Herombopag
Phase 2RecruitingInstitute of Hematology & Blood Diseases Hospital, China502022-03-142025-02-24
Herombopag + rhTPO in Severe Immune Thrombocytopenia
rhTPO, Herombopag - Immune Thrombocytopenia
Phase 3UnknownYin Jie902022-01-012022-04-26
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
Herombopag - Carcinoma;Blood
UnknownSuxiaLuo4982021-09-292021-11-23

Conditions studied

Purpura, Thrombocytopenic, Idiopathic (2)  ·  Hematologic Neoplasms (1)  ·  Lymphoma, Follicular (1)  ·  Radiation Injuries (1)  ·  Thrombocytopenia (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (2)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Peking University Cancer Hospital & Institute (1)  ·  SuxiaLuo (1)  ·  Yin Jie (1)  ·  Zhenzhen Liu (1)

Countries

China (5)

Top investigators

Jie Yin (1)  ·  Lei Zhang, MD (1)  ·  Xiaofan Li, Dr (1)

Results publications

PMID 19144680, PMID 20110050, PMID 2110385, PMID 26187614, PMID 29248399, PMID 29622384, PMID 30156363, PMID 30764783, PMID 30915164, PMID 33632264, PMID 41489450, PMID 8201386, PMID 9043028